We are live on ! Find out more
AFM

Anson Funds Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 370.24%
This Fund
S&P 500
This Quarter Est. Return
+13.41%
1 Year Est. Return
+370.24%
3 Year Est. Return
+1,243.07%
5 Year Est. Return
+867.54%
10 Year Est. Return
+12,575.88%
AUM
$144M
AUM Growth
-$27.9M
Cap. Flow
-$36M
Cap. Flow %
-24.94%
Top 10 Hldgs %
91.04%
Holding
68
New
13
Increased
10
Reduced
2
Closed
37

Top Buys

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$6.75M
2
OGEN icon
Oragenics
OGEN
+$2.61M
3
AGX icon
Argan
AGX
+$2.27M
4
TRNX
Taronis Technologies, Inc. Common Stock
TRNX
+$1.99M
5
TOON icon
Kartoon Studios
TOON
+$1.23M

Top Sells

Rank Stock Value
1
TLRY icon
Tilray
TLRY
+$99.4M
2
OTRK
Ontrak
OTRK
+$1.13M
3
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
+$987K
4
IRD
Opus Genetics
IRD
+$565K
5
VLRX
VALERITAS HOLDINGS INC
VLRX
+$563K

Sector Composition

Rank Sector Weight
1 Real Estate 5.79%
2 Consumer Discretionary 4.27%
3 Industrials 3.66%
4 Healthcare 1.82%
5 Energy 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VISL
26
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$268K 0.19%
638
+559
+708% +$253K
GPUS
27
Hyperscale Data Inc
GPUS
$54.6M
– –
0
– –
PHIOW
28
DELISTED
Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
$98K 0.07%
217,023
– –
MDGSW
29
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$62K 0.04%
21,000
– –
NSPRZ
30
DELISTED
InspireMD, Inc. Series B Warrants
NSPRZ
$35K 0.02%
250,000
– –
ALAR
31
Alarum Technologies
ALAR
$13.4M
– –
-320
Closed -$190K
C icon
32
CALL
Citigroup
C
$220B
– –
-117,000
Closed -$6.09M
CLDX icon
33
Celldex Therapeutics
CLDX
$2.8B
– –
-81,990
Closed -$243K
CLSD
34
DELISTED
Clearside Biomedical
CLSD
– –
-15,559
Closed -$250K
CRVO icon
35
CervoMed
CRVO
$23.9M
– –
-442
Closed -$66K
DIS icon
36
CALL
Walt Disney
DIS
$170B
– –
-65,000
Closed -$7.13M
GERN icon
37
Geron
GERN
$924M
– –
-171,203
Closed -$171K
GOOGL icon
38
CALL
Alphabet (Google) Class A
GOOGL
$4T
– –
-100,000
Closed -$5.22M
GS icon
39
CALL
Goldman Sachs
GS
$300B
– –
-32,500
Closed -$5.43M
NGNE icon
40
Neurogene
NGNE
$673M
– –
-10,970
Closed -$474K
OTRK
41
DELISTED
Ontrak
OTRK
– –
-1,342
Closed -$1.13M
PDSB icon
42
PDS Biotechnology
PDSB
$37.6M
– –
-12,171
Closed -$78K
RKDA icon
43
Arcadia Biosciences
RKDA
$1.36M
– –
-1,383
Closed -$175K
SISI
44
DELISTED
Shineco
SISI
– –
-1
Closed -$94K
SLB icon
45
CALL
SLB Ltd
SLB
$76.5B
– –
-381,900
Closed -$13.8M
SMSI icon
46
Smith Micro Software
SMSI
$13.6M
– –
-5,676
Closed -$409K
TLRY icon
47
Tilray
TLRY
$496M
– –
-140,881
Closed -$99.4M
TNXP icon
48
Tonix Pharmaceuticals
TNXP
$162M
– –
0
– -$68K
TOVX icon
49
Theriva Biologics
TOVX
$9.55M
– –
-628
Closed -$88K
UVXY icon
50
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$242M
– –
-79
Closed -$16.2M
1
2
3

Similar funds

RA
RPOA Advisors Plano, Texas $2.29B AUM 11.74% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
ST
Smithfield Trust Pittsburgh, Pennsylvania $2.3B AUM 14.87% 1-Year Est. Return
GCP
Greenoaks Capital Partners Orinda, California $2.3B AUM 19.87% 1-Year Est. Return
LCM
Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.27B AUM

Anson Funds Management's Q1 2019 Portfolio in Review

As of Q1 2019, Anson Funds Management held 68 positions worth $144M, down 16% from $172M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

Anson Funds Management withdrew a net $36M in Q1 2019, closing 37 positions and reducing 2 holdings. Its most notable exit was Tilray, an estimated $99.4M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 5.8% of assets, up from 2.8% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Anson Funds Management opened a new position in Bed Bath & Beyond worth $6.17M.

  • Anson Funds Management's largest Q1 2019 buy was Bed Bath & Beyond: 493,880 shares worth $6.17M.
  • Anson Funds Management added most to Argan in Q1 2019, an estimated $2.27M increase.
  • Anson Funds Management's biggest Q1 2019 reduction was Invitation Homes, cutting an estimated $114K.
  • Anson Funds Management fully exited Tilray in Q1 2019, selling an estimated $99.4M.
  • Anson Funds Management's ten largest holdings make up 91% of its $144M portfolio in Q1 2019.
  • Anson Funds Management opened 13 new positions and closed 37 in Q1 2019.
  • Anson Funds Management's portfolio value fell 16% quarter-over-quarter to $144M.

Based on Anson Funds Management's 13F filing for Q1 2019, filed 15 May 2019.